Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic equivalence study of two mometasone nasal sprays in seasonal allergic rhinitis
2013-001318-14Phase 3Completed
- Sponsor
- PHT Corporation
- Start
- May 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of mometasone in seasonal allergic rhinitis (SAR) (2 arms), sponsored by PHT Corporation. Primary endpoint: Change from baseline in average instantaneous PM Total Nasal Symptom Score. Started May 2013; status: completed.
02
Drugs
mometasone
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on 2013-001318-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001318-14.